Totally tubular, dude: rethinking DKD pathogenesis in the wake of SGLT2i data

被引：6
|
作者：
Yu, Samuel Mon-Wei [1 ]
Leventhal, Jeremy S. [2 ]
Cravedi, Paolo [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Med, Translat Transplant Res Ctr, New York, NY 10029 USA
[2] White Plains Hosp, Div Nephrol, White Plains, NY USA
来源：
JOURNAL OF NEPHROLOGY | 2021年 / 34卷 / 03期
关键词：
Sodium glucose co-transporter 2; Diabetic kidney disease; Proximal tubule; Tubuloglomerular feedback; Autophagy;
D O I：
10.1007/s40620-020-00868-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：629 / 631
页数：3
相关论文
共 50 条
  • [41] Characteristics of Inpatients with DKA and SGLT2i Use at a Tertiary Hospital
    Williamson, Shelley
    Taha, Mohamad B.
    Brown, Timothy R.
    Hebert, Sean
    Patel, Kershaw
    Narcisse, Victor J., III
    Sadhu, Archana R.
    DIABETES, 2022, 71
  • [42] SGLT2i After Kidney Transplantation: Ready for Prime Time?
    Francis, Ross Simon
    TRANSPLANTATION, 2022, 106 (09) : 1732 - 1733
  • [43] SGLT2i and loop diuretic withdrawal or downtitration in heart failure
    Domingo, Mar
    Ruiz-Cueto, Maria
    Teis, Albert
    Lupon, Josep
    Alonso, Nuria
    Bayes-Genis, Antoni
    REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (11): : 943 - 945
  • [44] Timing of SGLT2i initiation after acute myocardial infarction
    von Lewinski, Dirk
    Kolesnik, Ewald
    Aziz, Faisal
    Benedikt, Martin
    Tripolt, Norbert J.
    Wallner, Markus
    Pferschy, Peter N.
    von Lewinski, Friederike
    Schwegel, Nora
    Holman, Rury R.
    Oulhaj, Abderrahim
    Moertl, Deddo
    Siller-Matula, Jolanta
    Sourij, Harald
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [45] SGLT2i use increases risk of postoperative diabetic ketoacidosis
    Reactions Weekly, 2022, 1931 (1) : 12 - 12
  • [46] Cardiovascular outcome with SGLT2i and GLP1RA
    Lim, Soo
    Sohn, Minji
    Nauck, Michael A.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 129 : 133 - 136
  • [47] Risk of infection lower with SGLT2i than DPP4i
    Reactions Weekly, 2024, 2017 (1) : 10 - 10
  • [48] Drug-specific or class effects of SGLT2 inhibitors (SGLT2i) in the heart: SGLT2i inhibit NHE, reduce [Na+]c and induce vasodilation in isolated mouse cardiomyocytes/hearts
    Uthman, L.
    Baartscheer, A.
    Bleijlevens, B.
    Schumacher, C. A.
    Fiolet, J. W. T.
    Koeman, A.
    Hollmann, M. W.
    Weber, N. C.
    Coronel, R.
    Zuurbier, C. J.
    DIABETOLOGIA, 2017, 60 : S86 - S87
  • [49] Sodium-glucose cotransporter 2 inhibitors (SGLT2i): renal implications
    Castaneda, Alejandrina M.
    Dutra-Rufato, Amanda
    Juarez, Maria J.
    Grosembacher, Luis
    Gonzalez-Torres, Henry
    Musso, Carlos G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (02) : 291 - 299
  • [50] SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2
    Xiang Cai
    Huanyi Cao
    Meijun Wang
    Piaojian Yu
    Xiaoqi Liang
    Hua Liang
    Fen Xu
    Mengyin Cai
    Cellular and Molecular Life Sciences, 82 (1)
12345